MRRC.F Stock Overview
Produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Wayland Group Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
11 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 0% |
33 Year Change | -98.00% |
5 Year Change | -99.99% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
MRRC.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | 2.8% | 1.0% |
1Y | 0% | 13.3% | 31.4% |
Return vs Industry: MRRC.F underperformed the US Pharmaceuticals industry which returned 13.3% over the past year.
Return vs Market: MRRC.F underperformed the US Market which returned 31.4% over the past year.
Price Volatility
MRRC.F volatility | |
---|---|
MRRC.F Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 10.1% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.3% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MRRC.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine MRRC.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | n/a | n/a | www.waylandgroup.com |
Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. It offers a range of CBD, balanced, and THC strains under the Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann names. The company was founded in 2013 and is headquartered in Oakville, Canada.
Wayland Group Corp. Fundamentals Summary
MRRC.F fundamental statistics | |
---|---|
Market cap | US$237.00 |
Earnings (TTM) | -US$30.68m |
Revenue (TTM) | US$1.91m |
0.0x
P/S Ratio0.0x
P/E RatioIs MRRC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MRRC.F income statement (TTM) | |
---|---|
Revenue | CA$2.68m |
Cost of Revenue | CA$4.80m |
Gross Profit | -CA$2.12m |
Other Expenses | CA$40.84m |
Earnings | -CA$42.96m |
Last Reported Earnings
Sep 30, 2018
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did MRRC.F perform over the long term?
See historical performance and comparison